Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 45: 1235-1239, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edén Engström, B.
Right arrow Articles by Wide, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edén Engström, B.
Right arrow Articles by Wide, L.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1999;45:1235-1239.)
© 1999 American Association for Clinical Chemistry, Inc.


Articles

Gender Differences in Diurnal Growth Hormone and Epinephrine Values in Young Adults during Ambulation

Britt Edén Engströma, F. Anders Karlsson and Leif Wide

Department of Medical Sciences, University Hospital, S-751 85 Uppsala, Sweden.
a Address correspondence to this author at: Department of Medical Sciences, Internal Medicine, University Hospital, S-751 85 Uppsala, Sweden. Fax 46 18 55 36 01; e-mail Britt.Eden_Engstrom{at}medicin.uu.se

Background: In the present study, the impact of gender, oral contraceptives, and ambulation on serum growth hormone (GH) and urinary catecholamines was examined in healthy young adults.

Methods: Twenty-one medical student volunteers—7 men, 7 women, and 7 women taking oral contraceptives—were investigated. Serum samples were drawn every second hour during a 24-h period. At 0800 the first morning, serum samples were drawn while subjects were in the ambulatory state; the next morning, serum samples were drawn at 0800 while the subjects were still resting in bed.

Results: During the daytime, GH concentrations were sevenfold higher in the women than in the men, a difference larger than described previously. During the night, there was no gender difference. In the morning, ambulatory GH concentrations were 28-fold higher in the women than in the men, whereas supine GH concentrations were only 4.6-fold higher in the women than in the men. Daytime urinary output of epinephrine was lower in the women than in the men, whereas there was no difference at night. Women using estrogen-containing oral contraceptives had lower epinephrine and higher GH values than women not taking oral contraceptives. In women, morning GH concentrations were higher in the ambulatory than in the resting state, whereas they were lower in the ambulatory state than in the resting state in men.

Conclusions: The secretion of GH and epinephrine is gender-dependent and differs during the daytime in a reciprocal manner, with higher GH and lower epinephrine in women than in men. Oral contraceptives appear to further increase such differences. It seems likely that the data reflect a gender difference in the utilization of substrates for energy production.© 1999 American Association for Clinical Chemistry




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
H. Markkanen, T. Pekkarinen, M. J. Valimaki, H. Alfthan, R. Kauppinen-Makelin, T. Sane, and U.-H. Stenman
Effect of Sex and Assay Method on Serum Concentrations of Growth Hormone in Patients with Acromegaly and in Healthy Controls
Clin. Chem., March 1, 2006; 52(3): 468 - 473.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. E. Engstrom, P. Burman, C. Holdstock, M. Ohrvall, M. Sundbom, and F A. Karlsson
Effects of gastric bypass on the GH/IGF-I axis in severe obesity - and a comparison with GH deficiency
Eur. J. Endocrinol., January 1, 2006; 154(1): 53 - 59.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Wang, Y.-H. Feng, and G. I. Gorodeski
Epidermal Growth Factor Facilitates Epinephrine Inhibition of P2X7-Receptor-Mediated Pore Formation and Apoptosis: A Novel Signaling Network
Endocrinology, January 1, 2005; 146(1): 164 - 174.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.